Peptides from the endozepine family, including diazepam-binding inhibitor (DBI), are regulatory neuropeptides originally isolated from rat brain tissue as factors potentially able to displace benzodiazepines from their binding sites [1]. leading to multiple complications. The term morbid obesity, or class III obesity according to the WHO, is used to describe adults with a body mass… Continue reading Peptides from the endozepine family, including diazepam-binding inhibitor (DBI), are regulatory